High-Throughput Platform for Identifying Molecular Factors Involved in Phenotypic Stabilization of Primary Human...

Area of Science:

• Hepatology and Cell Biology
• Biotechnology and Bioengineering

Background:

• Liver disease poses a significant global health burden with limited treatment options beyond transplantation.
• Hepatocyte cell-based therapies are promising but challenged by rapid loss of liver-specific functions in culture.
• Current understanding of mechanisms maintaining hepatocyte function in vitro is incomplete.

Purpose of the Study:

• To develop a high-throughput platform for systematic investigation of liver biology in vitro.
• To identify factors critical for maintaining hepatocyte viability and liver-specific functions in culture.

Main Methods:

• Development of a high-throughput platform for genetic knockdown screens.
• Utilized an enzyme-linked immunosorbent assay (ELISA) to measure albumin output as a marker of synthetic function.
• Employed an image-based viability assay to count hepatocyte nuclei.

Main Results:

• Successfully developed and implemented a high-throughput screening platform for in vitro liver research.
• Identified 12 gene products potentially important for hepatocyte viability and/or liver identity in vitro.
• The platform enables functional and viability assays for cultured hepatocytes.

Conclusions:

• The developed platform is a valuable tool for systematically interrogating liver biology in vitro.
• The identified gene products are key targets for understanding and maintaining hepatocyte function in culture.
• This work provides a foundation for advancing cell-based therapies for liver diseases.